Holen Sie sich die Stockscreener-App
1.51
9.42%
0.13
Handel nachbörslich:
1.55
0.04
+2.65%
Schlusskurs vom Vortag:
$1.38
Offen:
$1.43
24-Stunden-Volumen:
4.34M
Relative Volume:
3.15
Marktkapitalisierung:
$242.77M
Einnahmen:
$156.37M
Nettoeinkommen (Verlust:
$-37.49M
KGV:
-7.1905
EPS:
-0.21
Netto-Cashflow:
$-47.77M
1W Leistung:
+18.90%
1M Leistung:
+20.80%
6M Leistung:
-15.17%
1J Leistung:
-20.11%
1-Tages-Spanne:
$1.39
$1.58
1-Wochen-Bereich:
$1.245
$1.58
52-Wochen-Spanne:
$1.12
$2.54
Cerus Corp Stock (CERS) Company Profile
Firmenname
Cerus Corp
Sektor
Branche
Telefon
(925) 288-6000
Adresse
1220 CONCORD AVENUE, CONCORD, CA
Vergleichen Sie CERS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.51 | 242.77M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-12 | Eingeleitet | Craig Hallum | Buy |
| 2023-01-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-17 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Eingeleitet | BTIG Research | Buy |
| 2019-11-13 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-08-28 | Eingeleitet | Stifel | Buy |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Fortgesetzt | BTIG Research | Neutral |
| 2016-07-07 | Fortgesetzt | Cantor Fitzgerald | Buy |
| 2015-12-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2014-05-02 | Bestätigt | MLV & Co | Buy |
| 2013-04-24 | Bestätigt | Cantor Fitzgerald | Buy |
| 2013-03-15 | Bestätigt | MLV & Co | Buy |
| 2012-04-17 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2012-02-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Bestätigt | MLV & Co | Buy |
| 2011-06-03 | Eingeleitet | Wedbush | Outperform |
| 2011-03-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Hochstufung | Avondale | Mkt Perform → Mkt Outperform |
Alle ansehen
Cerus Corp Aktie (CERS) Neueste Nachrichten
Mackenzie Financial Corp Acquires 17,704 Shares of Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) - Defense World
3 Promising Penny Stocks With Market Caps Over $90M - Yahoo Finance
Cerus Management Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Coming June 11 - Stock Titan
Cantor Fitzgerald maintains Cerus stock rating due to regulatory approvals By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains Cerus stock rating due to regulatory approvals - Investing.com
Cerus to present new INTERCEPT Blood System data at ISBT Congress - Investing.com
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan - Yahoo Finance
Cerus (CERS) Gains French and Swiss Regulatory Approvals for New Device | CERS Stock News - GuruFocus
Cerus gains regulatory nods for blood safety device in Europe - Investing.com
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device - Yahoo Finance
Cerus Co. (NASDAQ:CERS) Stake Boosted by Jane Street Group LLC - Defense World
When Should You Buy Cerus Corporation (NASDAQ:CERS)? - Yahoo Finance
Price T Rowe Associates Inc. MD Buys 34,694 Shares of Cerus Co. (NASDAQ:CERS) - Defense World
Stifel Financial Corp Grows Stock Position in Cerus Co. (NASDAQ:CERS) - Defense World
Raymond James Financial Inc. Acquires Shares of 244,073 Cerus Co. (NASDAQ:CERS) - Defense World
Closing Strong: Cerus Corp (CERS) Ends at 1.25, Down -3.85 from Last Close - DWinneX
Cerus Corporation Announces First Quarter 2025 Financial Results - ADVFN
Analysts Offer Insights on Healthcare Companies: Cerus (CERS), Stryker (SYK) and Praxis Precision Medicines (PRAX) - The Globe and Mail
JPMorgan Chase & Co. Grows Stock Holdings in Cerus Co. (NASDAQ:CERS) - Defense World
Cerus Corporation (NASDAQ:CERS) Just Reported, And Analysts Assigned A US$4.25 Price Target - Yahoo Finance
Cerus Corporation (NASDAQ:CERS) Q1 2025 Earnings Call Transcript - Insider Monkey
Cerus Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Cerus: Q1 Earnings Snapshot - MySA
Earnings call transcript: Cerus Q1 2025 revenue up, stock dips post-earnings - Investing.com
CERUS CORP SEC 10-Q Report - TradingView
Cerus Corp Reports Q1 2025 Earnings: EPS Matches Estimate at -$0 - GuruFocus
Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Cerus Corp (CERS) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Cerus Corp (CERS) deserves deeper analysis - uspostnews.com
Trading Day Review: Cerus Corp (CERS) Loses Momentum, Closing at 1.34 - DWinneX
Geode Capital Management LLC Grows Stock Position in Cerus Co. (NASDAQ:CERS) - Defense World
Cerus Corp (NASDAQ:CERS) Price Forecast For The Next 12 Months Is Set At 5. - Marketing Sentinel
Cerus Corp (CERS) deserves closer scrutiny - uspostnews.com
Vanguard Group Inc. Has $16.04 Million Stock Holdings in Cerus Co. (NASDAQ:CERS) - Defense World
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025 - Yahoo Finance
Lobbying Update: $40,000 of CERUS CORPORATION lobbying was just disclosed - Nasdaq
After losing 21% in the past year, Cerus Corporation (NASDAQ:CERS) institutional owners must be relieved by the recent gain - simplywall.st
Raymond James Financial Inc. Purchases Shares of 244,073 Cerus Co. (NASDAQ:CERS) - Defense World
Cerus stock touches 52-week low at $1.19 amid market challenges - Investing.com
Virtu Financial LLC Takes $33,000 Position in Cerus Co. (NASDAQ:CERS) - Defense World
How Are Things Looking For Cerus Corp (NASDAQ: CERS) For The Short Term? - stocksregister.com
Quantbot Technologies LP Acquires Shares of 52,913 Cerus Co. (NASDAQ:CERS) - Defense World
Head to Head Analysis: Cerus (NASDAQ:CERS) & DIH Holding US (NASDAQ:DHAI) - Defense World
Cerus stock touches 52-week low at $1.37 amid market challenges - Investing.com Australia
Cerus Co. (NASDAQ:CERS) Stock Holdings Decreased by Charles Schwab Investment Management Inc. - Defense World
Is it possible to buy Cerus Corp(CERS) shares at a good price now? - uspostnews.com
Connor Clark & Lunn Investment Management Ltd. Increases Stock Position in Cerus Co. (NASDAQ:CERS) - Defense World
Cerus Leads Our Selection Of 3 Promising Penny Stocks - Yahoo Finance
CERUS CORP Executives Sell Shares - TradingView
Analysts Predict How High Cerus Corp (CERS) Will Go. - Stocks Register
Closing Bell Recap: Cerus Corp (CERS) Ends at 1.48, Reflecting a -0.67 Downturn - The Dwinnex
Finanzdaten der Cerus Corp-Aktie (CERS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cerus Corp-Aktie (CERS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
| Jensen Chrystal | Chief Legal Officer |
Mar 07 '25 |
Sale |
1.50 |
27,457 |
41,131 |
832,318 |
0.56%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):